VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-7.72 Cr | ₹-4.24 Cr | ₹-1.99 Cr | ₹-0.90 Cr | ₹-0.44 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VIMTA LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2024 | ₹-7.72 Cr |
| Mar2023 | ₹-4.24 Cr |
| Mar2022 | ₹-1.99 Cr |
| Mar2021 | ₹-0.90 Cr |
| Mar2020 | ₹-0.44 Cr |
How is Deferred Tax Assets / Liabilities of VIMTA LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-7.72 Cr | Negative | |
| Mar2023 | ₹-4.24 Cr | Negative | |
| Mar2022 | ₹-1.99 Cr | Negative | |
| Mar2021 | ₹-0.90 Cr | Negative | |
| Mar2020 | ₹-0.44 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,872.9 Cr | 10% | -2.5% | -17.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 10% |
-2.5% |
-17.3% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses